financetom
Business
financetom
/
Business
/
Transcat Fiscal Q3 Adjusted Earnings Fall, Revenue Rises -- Shares Drop After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Transcat Fiscal Q3 Adjusted Earnings Fall, Revenue Rises -- Shares Drop After Hours
Jan 27, 2025 2:55 PM

05:30 PM EST, 01/27/2025 (MT Newswires) -- Transcat ( TRNS ) reported fiscal Q3 adjusted earnings late Monday of $0.45 per diluted share, down from $0.56 a year earlier.

Three analysts polled by FactSet expected $0.50.

Revenue for the quarter ended Dec. 28 rose to $66.8 million from $65.2 million a year earlier.

Four analysts surveyed by FactSet expected $70.3 million.

The company's shares were down nearly 5% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Usana Health Sciences Insider Sold Shares Worth $257,022, According to a Recent SEC Filing
Usana Health Sciences Insider Sold Shares Worth $257,022, According to a Recent SEC Filing
Mar 11, 2024
02:32 PM EDT, 03/11/2024 (MT Newswires) -- Walter Noot, COO, on March 08, 2024, sold 5,240 shares in Usana Health Sciences ( USNA ) for $257,022. SEC Filing: https://www.sec.gov/Archives/edgar/data/896264/000089626424000113/xslF345X03/wk-form4_1710181361.xml Price: 49.05, Change: +0.47, Percent Change: +0.97 ...
Usana Health Sciences Insider Sold Shares Worth $539,539, According to a Recent SEC Filing
Usana Health Sciences Insider Sold Shares Worth $539,539, According to a Recent SEC Filing
Mar 11, 2024
02:33 PM EDT, 03/11/2024 (MT Newswires) -- Kevin Guest, Executive Chairman of the Board, on March 11, 2024, sold 11,011 shares in Usana Health Sciences ( USNA ) for $539,539. Following the Form 4 filing with the SEC, Guest has control over a total of 10,491 shares of the company, with 10,491 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/896264/000089626424000115/xslF345X03/wk-form4_1710181559.xml Price: 49.12,...
Moderna, Merck to Begin Phase 2/3 Study of V940 Plus Pembrolizumab in Skin Cancer
Moderna, Merck to Begin Phase 2/3 Study of V940 Plus Pembrolizumab in Skin Cancer
Mar 11, 2024
02:26 PM EDT, 03/11/2024 (MT Newswires) -- Moderna ( MRNA ) and Merck ( MRK ) will start a phase 2/3 study of cancer vaccine V940, or mRNA-4157, plus pembrolizumab in patients with cutaneous squamous cell carcinoma, a form of skin cancer, according to a government trial website. The study is expected to begin on April 18, according to ClinicalTrials.gov....
--Street Color: Apple Opening New Store in Shanghai March 21
--Street Color: Apple Opening New Store in Shanghai March 21
Mar 11, 2024
02:34 PM EDT, 03/11/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 172.46, Change: +1.73, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved